1.7 Healthcare Reimbursement Systems Across Care Settings

1.7 Healthcare Reimbursement Systems Across Care Settings

The PTCB Billing and Reimbursement content outline explicitly tests healthcare reimbursement systems in different settings — because the identical drug can travel through entirely different benefit structures, claim formats, and payment formulas depending on where the patient receives care. A single course of antibiotics, for example, is bundled into an MS-DRG payment during an inpatient admission, adjudicated in real time under the pharmacy benefit when dispensed as oral step-down therapy at a community pharmacy, and reimbursed under the medical benefit when infused at home through durable equipment.

Billing specialists must instantly recognize which reimbursement system governs a given site of care, which claim standard applies (NCPDP D.0 vs. CMS-1500/837P vs. UB-04/837I), and how bundling rules determine whether a drug is separately billable at all.

1. Hospitals: Bundled Inpatient vs. Itemized Outpatient Billing

• Inpatient (Part A): Medicare pays acute-care hospitals a single prospectively determined MS-DRG (Medicare Severity Diagnosis-Related Group) case rate per discharge. Every tablet, IV bag, and supply used during the admission is absorbed into that bundle — pharmacies never submit NCPDP or CMS-1500 claims for individual inpatient drugs. Skilled nursing facility stays following a qualifying 3-day inpatient admission are paid under the Patient-Driven Payment Model (PDPM) per-diem, which likewise bundles routine drug costs.
• Hospital Outpatient Departments (Part B / OPPS): Hospital outpatient clinics and infusion suites bill Medicare Part B under the Outpatient Prospective Payment System (OPPS), which packages services into Ambulatory Payment Classifications (APCs). Separately payable physician-administered drugs reimburse at ASP + 6% under buy-and-bill (Section 5.1), with claims carrying HCPCS J-codes, CPT administration codes, and JW/JZ wastage modifiers (Section 5.2).

2. Long-Term Care Pharmacy Reimbursement

Long-term care reimbursement hinges on whether the resident is in a post-acute Medicare Part A SNF stay or a custodial long-term stay:

• Part A SNF Stay (up to 100 days per benefit period): All medications are bundled into the facility's PDPM per-diem; the LTC pharmacy bills the nursing facility under contract rather than a third-party plan.
• Custodial Residents: Medicaid typically pays room and board, while prescription drugs for dual-eligible residents are billed by the LTC pharmacy to Medicare Part D through real-time NCPDP claims (Medicaid remains the payer of last resort).
• CMS Short-Cycle Dispensing Mandate: To reduce waste from therapy changes, discharges, and dose adjustments, Part D plans must require LTC pharmacies to dispense brand-name oral solid maintenance drugs to LTC residents in 14-day-or-less dispensing cycles (tracked with LTC-specific Submission Clarification Codes) rather than traditional 30-day fills.

3. Home Infusion & Home Health

• Home Infusion: For Medicare beneficiaries, IV drugs administered at home are covered under Part B only when the drug requires durable medical equipment — typically an external ambulatory infusion pump (e.g., certain IV antibiotics, inotropes such as dobutamine, or immune globulin). The drug and pump bill to the DME MAC; the 21st Century Cures Act additionally created a Part B professional services benefit that pays accredited home infusion suppliers a per-diem for nursing visits, training, and monitoring. Commercial payers typically reimburse home infusion under the medical benefit as a negotiated per-diem plus drug and supply bundle, requiring ACHC or Joint Commission accreditation.
• Home Health: Medicare pays certified home health agencies a bundled 30-day episode payment under the Patient-Driven Groupings Model (PDGM). Routine medications and supplies used during the episode are bundled and cannot be billed separately; only DME (e.g., walkers, wound-care supplies) is carved out and billed to the DME MACs.

4. Ambulatory Clinics & Community Pharmacy

• Ambulatory Clinics / Physician Offices: Operate under the medical benefit with buy-and-bill economics (ASP + 6%), CMS-1500/837P claims, and — increasingly — pharmacist-delivered services (Annual Wellness Visits, Chronic Care Management, MTM) billed under incident-to arrangements with supervising physicians (detailed in Section 5.2).
• Community Pharmacy: The dominant pharmacy-benefit channel: real-time NCPDP D.0 adjudication to PBMs, tiered copays, and point-of-sale DUR. Mail-order and specialty pharmacies use the same standard with 90-day supply economics and limited-distribution exclusivity.

[!NOTE] Exam Trap: The same product changes coverage pathway purely by site of care. Albuterol solution billed through a home nebulizer is Part B DME; the same patient's handheld inhaler at retail is Part D; the same drug during an inpatient admission is invisible inside the MS-DRG bundle.